nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2C9—Disulfiram—alcohol dependence	0.12	0.291	CbGbCtD
Irbesartan—CYP1A2—Citalopram—alcohol dependence	0.0952	0.23	CbGbCtD
Irbesartan—CYP2D6—Citalopram—alcohol dependence	0.0784	0.189	CbGbCtD
Irbesartan—CYP3A4—Disulfiram—alcohol dependence	0.07	0.169	CbGbCtD
Irbesartan—CYP3A4—Citalopram—alcohol dependence	0.0499	0.12	CbGbCtD
Irbesartan—JUN—nerve—alcohol dependence	0.00621	0.0742	CbGeAlD
Irbesartan—UGT1A3—digestive system—alcohol dependence	0.00319	0.0381	CbGeAlD
Irbesartan—JUN—brainstem—alcohol dependence	0.00266	0.0319	CbGeAlD
Irbesartan—UGT1A3—endocrine gland—alcohol dependence	0.00264	0.0315	CbGeAlD
Irbesartan—EDNRA—adrenal cortex—alcohol dependence	0.00261	0.0312	CbGeAlD
Irbesartan—JUN—forebrain—alcohol dependence	0.00257	0.0307	CbGeAlD
Irbesartan—JUN—adrenal cortex—alcohol dependence	0.00238	0.0285	CbGeAlD
Irbesartan—UGT1A3—liver—alcohol dependence	0.00238	0.0284	CbGeAlD
Irbesartan—JUN—cardiovascular system—alcohol dependence	0.00217	0.026	CbGeAlD
Irbesartan—JUN—pancreas—alcohol dependence	0.00211	0.0253	CbGeAlD
Irbesartan—JUN—gonad—alcohol dependence	0.00197	0.0236	CbGeAlD
Irbesartan—AGTR1—forebrain—alcohol dependence	0.00194	0.0231	CbGeAlD
Irbesartan—EDNRA—midbrain—alcohol dependence	0.00186	0.0222	CbGeAlD
Irbesartan—JUN—digestive system—alcohol dependence	0.00181	0.0216	CbGeAlD
Irbesartan—AGTR1—adrenal cortex—alcohol dependence	0.00179	0.0214	CbGeAlD
Irbesartan—JUN—blood—alcohol dependence	0.00172	0.0206	CbGeAlD
Irbesartan—JUN—midbrain—alcohol dependence	0.0017	0.0203	CbGeAlD
Irbesartan—AGTR1—cardiovascular system—alcohol dependence	0.00164	0.0196	CbGeAlD
Irbesartan—EDNRA—testis—alcohol dependence	0.00156	0.0186	CbGeAlD
Irbesartan—JUN—endocrine gland—alcohol dependence	0.00149	0.0178	CbGeAlD
Irbesartan—JUN—testis—alcohol dependence	0.00142	0.017	CbGeAlD
Irbesartan—JUN—nervous system—alcohol dependence	0.0014	0.0167	CbGeAlD
Irbesartan—JUN—liver—alcohol dependence	0.00134	0.0161	CbGeAlD
Irbesartan—JUN—central nervous system—alcohol dependence	0.00134	0.0161	CbGeAlD
Irbesartan—JUN—cerebellum—alcohol dependence	0.00131	0.0157	CbGeAlD
Irbesartan—AGTR1—blood—alcohol dependence	0.0013	0.0155	CbGeAlD
Irbesartan—EDNRA—brain—alcohol dependence	0.00117	0.014	CbGeAlD
Irbesartan—AGTR1—endocrine gland—alcohol dependence	0.00112	0.0134	CbGeAlD
Irbesartan—AGTR1—testis—alcohol dependence	0.00107	0.0128	CbGeAlD
Irbesartan—JUN—brain—alcohol dependence	0.00107	0.0128	CbGeAlD
Irbesartan—AGTR1—nervous system—alcohol dependence	0.00105	0.0126	CbGeAlD
Irbesartan—AGTR1—liver—alcohol dependence	0.00101	0.0121	CbGeAlD
Irbesartan—AGTR1—central nervous system—alcohol dependence	0.00101	0.0121	CbGeAlD
Irbesartan—PTGS1—forebrain—alcohol dependence	0.000851	0.0102	CbGeAlD
Irbesartan—AGTR1—brain—alcohol dependence	0.000804	0.00961	CbGeAlD
Irbesartan—CYP2C9—cardiovascular system—alcohol dependence	0.000789	0.00943	CbGeAlD
Irbesartan—CYP2D6—brainstem—alcohol dependence	0.000725	0.00867	CbGeAlD
Irbesartan—PTGS1—cardiovascular system—alcohol dependence	0.00072	0.00861	CbGeAlD
Irbesartan—CYP2C8—blood—alcohol dependence	0.000702	0.00839	CbGeAlD
Irbesartan—CYP2D6—forebrain—alcohol dependence	0.0007	0.00837	CbGeAlD
Irbesartan—Haemolytic anaemia—Citalopram—alcohol dependence	0.000698	0.00229	CcSEcCtD
Irbesartan—Dizziness—Disulfiram—alcohol dependence	0.000694	0.00228	CcSEcCtD
Irbesartan—CYP1A2—digestive system—alcohol dependence	0.00069	0.00824	CbGeAlD
Irbesartan—Hepatitis—Naltrexone—alcohol dependence	0.000688	0.00226	CcSEcCtD
Irbesartan—Injury—Citalopram—alcohol dependence	0.000686	0.00225	CcSEcCtD
Irbesartan—Pharyngitis—Naltrexone—alcohol dependence	0.000683	0.00224	CcSEcCtD
Irbesartan—Tinnitus—Acamprosate—alcohol dependence	0.000678	0.00223	CcSEcCtD
Irbesartan—Connective tissue disorder—Naltrexone—alcohol dependence	0.000676	0.00222	CcSEcCtD
Irbesartan—Hot flush—Citalopram—alcohol dependence	0.000674	0.00221	CcSEcCtD
Irbesartan—Increased appetite—Citalopram—alcohol dependence	0.000671	0.0022	CcSEcCtD
Irbesartan—Menopausal symptoms—Citalopram—alcohol dependence	0.000668	0.0022	CcSEcCtD
Irbesartan—Visual disturbance—Citalopram—alcohol dependence	0.000665	0.00219	CcSEcCtD
Irbesartan—Rash—Disulfiram—alcohol dependence	0.000661	0.00217	CcSEcCtD
Irbesartan—Headache—Disulfiram—alcohol dependence	0.000657	0.00216	CcSEcCtD
Irbesartan—CYP1A2—blood—alcohol dependence	0.000657	0.00785	CbGeAlD
Irbesartan—Immune system disorder—Acamprosate—alcohol dependence	0.000657	0.00216	CcSEcCtD
Irbesartan—CYP2C9—digestive system—alcohol dependence	0.000655	0.00783	CbGeAlD
Irbesartan—Chills—Acamprosate—alcohol dependence	0.000653	0.00214	CcSEcCtD
Irbesartan—Arthritis—Citalopram—alcohol dependence	0.000648	0.00213	CcSEcCtD
Irbesartan—Cerebrovascular accident—Citalopram—alcohol dependence	0.000643	0.00211	CcSEcCtD
Irbesartan—Tinnitus—Naltrexone—alcohol dependence	0.000642	0.00211	CcSEcCtD
Irbesartan—Cardiac disorder—Naltrexone—alcohol dependence	0.000639	0.0021	CcSEcCtD
Irbesartan—Malnutrition—Acamprosate—alcohol dependence	0.000633	0.00208	CcSEcCtD
Irbesartan—Hyponatraemia—Citalopram—alcohol dependence	0.000633	0.00208	CcSEcCtD
Irbesartan—Angiopathy—Naltrexone—alcohol dependence	0.000624	0.00205	CcSEcCtD
Irbesartan—Flatulence—Acamprosate—alcohol dependence	0.000624	0.00205	CcSEcCtD
Irbesartan—CYP2C9—blood—alcohol dependence	0.000624	0.00745	CbGeAlD
Irbesartan—Immune system disorder—Naltrexone—alcohol dependence	0.000621	0.00204	CcSEcCtD
Irbesartan—Tension—Acamprosate—alcohol dependence	0.000621	0.00204	CcSEcCtD
Irbesartan—Affect lability—Citalopram—alcohol dependence	0.00062	0.00204	CcSEcCtD
Irbesartan—Mediastinal disorder—Naltrexone—alcohol dependence	0.00062	0.00204	CcSEcCtD
Irbesartan—Dysgeusia—Acamprosate—alcohol dependence	0.00062	0.00204	CcSEcCtD
Irbesartan—Chills—Naltrexone—alcohol dependence	0.000617	0.00203	CcSEcCtD
Irbesartan—Nervousness—Acamprosate—alcohol dependence	0.000615	0.00202	CcSEcCtD
Irbesartan—CYP2C8—endocrine gland—alcohol dependence	0.000609	0.00728	CbGeAlD
Irbesartan—Muscle spasms—Acamprosate—alcohol dependence	0.000609	0.002	CcSEcCtD
Irbesartan—Face oedema—Citalopram—alcohol dependence	0.000608	0.002	CcSEcCtD
Irbesartan—Malnutrition—Naltrexone—alcohol dependence	0.000599	0.00197	CcSEcCtD
Irbesartan—PTGS1—digestive system—alcohol dependence	0.000598	0.00714	CbGeAlD
Irbesartan—Mood swings—Citalopram—alcohol dependence	0.000597	0.00196	CcSEcCtD
Irbesartan—Tremor—Acamprosate—alcohol dependence	0.000593	0.00195	CcSEcCtD
Irbesartan—Flatulence—Naltrexone—alcohol dependence	0.00059	0.00194	CcSEcCtD
Irbesartan—Tension—Naltrexone—alcohol dependence	0.000588	0.00193	CcSEcCtD
Irbesartan—Ill-defined disorder—Acamprosate—alcohol dependence	0.000587	0.00193	CcSEcCtD
Irbesartan—Dysgeusia—Naltrexone—alcohol dependence	0.000587	0.00193	CcSEcCtD
Irbesartan—Anaemia—Acamprosate—alcohol dependence	0.000585	0.00192	CcSEcCtD
Irbesartan—Liver function test abnormal—Citalopram—alcohol dependence	0.000582	0.00191	CcSEcCtD
Irbesartan—Agitation—Acamprosate—alcohol dependence	0.000582	0.00191	CcSEcCtD
Irbesartan—Nervousness—Naltrexone—alcohol dependence	0.000582	0.00191	CcSEcCtD
Irbesartan—CYP2C8—testis—alcohol dependence	0.000581	0.00694	CbGeAlD
Irbesartan—Angioedema—Acamprosate—alcohol dependence	0.000578	0.0019	CcSEcCtD
Irbesartan—Muscle spasms—Naltrexone—alcohol dependence	0.000576	0.00189	CcSEcCtD
Irbesartan—Abdominal pain upper—Citalopram—alcohol dependence	0.000576	0.00189	CcSEcCtD
Irbesartan—Orthostatic hypotension—Citalopram—alcohol dependence	0.000576	0.00189	CcSEcCtD
Irbesartan—Hypokalaemia—Citalopram—alcohol dependence	0.000574	0.00188	CcSEcCtD
Irbesartan—Malaise—Acamprosate—alcohol dependence	0.000571	0.00188	CcSEcCtD
Irbesartan—CYP1A2—endocrine gland—alcohol dependence	0.00057	0.00681	CbGeAlD
Irbesartan—Breast disorder—Citalopram—alcohol dependence	0.000569	0.00187	CcSEcCtD
Irbesartan—PTGS1—blood—alcohol dependence	0.000569	0.00681	CbGeAlD
Irbesartan—Vertigo—Acamprosate—alcohol dependence	0.000569	0.00187	CcSEcCtD
Irbesartan—Syncope—Acamprosate—alcohol dependence	0.000568	0.00187	CcSEcCtD
Irbesartan—Cramp muscle—Citalopram—alcohol dependence	0.000567	0.00187	CcSEcCtD
Irbesartan—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000567	0.00187	CcSEcCtD
Irbesartan—Leukopenia—Acamprosate—alcohol dependence	0.000567	0.00186	CcSEcCtD
Irbesartan—Vision blurred—Naltrexone—alcohol dependence	0.000564	0.00186	CcSEcCtD
Irbesartan—Nasopharyngitis—Citalopram—alcohol dependence	0.000564	0.00185	CcSEcCtD
Irbesartan—Tremor—Naltrexone—alcohol dependence	0.000561	0.00184	CcSEcCtD
Irbesartan—Loss of consciousness—Acamprosate—alcohol dependence	0.000556	0.00183	CcSEcCtD
Irbesartan—Muscular weakness—Citalopram—alcohol dependence	0.000556	0.00183	CcSEcCtD
Irbesartan—Ill-defined disorder—Naltrexone—alcohol dependence	0.000556	0.00183	CcSEcCtD
Irbesartan—Cough—Acamprosate—alcohol dependence	0.000552	0.00182	CcSEcCtD
Irbesartan—Agitation—Naltrexone—alcohol dependence	0.00055	0.00181	CcSEcCtD
Irbesartan—CYP2C8—liver—alcohol dependence	0.000549	0.00656	CbGeAlD
Irbesartan—Abdominal distension—Citalopram—alcohol dependence	0.000548	0.0018	CcSEcCtD
Irbesartan—Angioedema—Naltrexone—alcohol dependence	0.000547	0.0018	CcSEcCtD
Irbesartan—Hypertension—Acamprosate—alcohol dependence	0.000547	0.0018	CcSEcCtD
Irbesartan—Dysphagia—Citalopram—alcohol dependence	0.000545	0.00179	CcSEcCtD
Irbesartan—Asthma—Citalopram—alcohol dependence	0.000545	0.00179	CcSEcCtD
Irbesartan—Influenza—Citalopram—alcohol dependence	0.000545	0.00179	CcSEcCtD
Irbesartan—CYP2C9—endocrine gland—alcohol dependence	0.000541	0.00647	CbGeAlD
Irbesartan—Malaise—Naltrexone—alcohol dependence	0.00054	0.00178	CcSEcCtD
Irbesartan—Myalgia—Acamprosate—alcohol dependence	0.000539	0.00177	CcSEcCtD
Irbesartan—Arthralgia—Acamprosate—alcohol dependence	0.000539	0.00177	CcSEcCtD
Irbesartan—Chest pain—Acamprosate—alcohol dependence	0.000539	0.00177	CcSEcCtD
Irbesartan—Syncope—Naltrexone—alcohol dependence	0.000537	0.00177	CcSEcCtD
Irbesartan—Anxiety—Acamprosate—alcohol dependence	0.000537	0.00177	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000535	0.00176	CcSEcCtD
Irbesartan—Pancreatitis—Citalopram—alcohol dependence	0.000534	0.00176	CcSEcCtD
Irbesartan—Discomfort—Acamprosate—alcohol dependence	0.000532	0.00175	CcSEcCtD
Irbesartan—Angina pectoris—Citalopram—alcohol dependence	0.000531	0.00174	CcSEcCtD
Irbesartan—Dry mouth—Acamprosate—alcohol dependence	0.000527	0.00173	CcSEcCtD
Irbesartan—Loss of consciousness—Naltrexone—alcohol dependence	0.000526	0.00173	CcSEcCtD
Irbesartan—Cough—Naltrexone—alcohol dependence	0.000523	0.00172	CcSEcCtD
Irbesartan—Hypertension—Naltrexone—alcohol dependence	0.000517	0.0017	CcSEcCtD
Irbesartan—Anaphylactic shock—Acamprosate—alcohol dependence	0.000517	0.0017	CcSEcCtD
Irbesartan—CYP1A2—liver—alcohol dependence	0.000514	0.00614	CbGeAlD
Irbesartan—Infection—Acamprosate—alcohol dependence	0.000513	0.00169	CcSEcCtD
Irbesartan—Myalgia—Naltrexone—alcohol dependence	0.00051	0.00168	CcSEcCtD
Irbesartan—Arthralgia—Naltrexone—alcohol dependence	0.00051	0.00168	CcSEcCtD
Irbesartan—Chest pain—Naltrexone—alcohol dependence	0.00051	0.00168	CcSEcCtD
Irbesartan—Shock—Acamprosate—alcohol dependence	0.000508	0.00167	CcSEcCtD
Irbesartan—Anxiety—Naltrexone—alcohol dependence	0.000508	0.00167	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000506	0.00166	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000506	0.00166	CcSEcCtD
Irbesartan—Thrombocytopenia—Acamprosate—alcohol dependence	0.000506	0.00166	CcSEcCtD
Irbesartan—Tachycardia—Acamprosate—alcohol dependence	0.000504	0.00166	CcSEcCtD
Irbesartan—Discomfort—Naltrexone—alcohol dependence	0.000504	0.00166	CcSEcCtD
Irbesartan—Skin disorder—Acamprosate—alcohol dependence	0.000502	0.00165	CcSEcCtD
Irbesartan—Hyperhidrosis—Acamprosate—alcohol dependence	0.000499	0.00164	CcSEcCtD
Irbesartan—CYP3A4—digestive system—alcohol dependence	0.000499	0.00597	CbGeAlD
Irbesartan—Dry mouth—Naltrexone—alcohol dependence	0.000499	0.00164	CcSEcCtD
Irbesartan—Photosensitivity reaction—Citalopram—alcohol dependence	0.000497	0.00163	CcSEcCtD
Irbesartan—Weight increased—Citalopram—alcohol dependence	0.000496	0.00163	CcSEcCtD
Irbesartan—PTGS1—endocrine gland—alcohol dependence	0.000494	0.0059	CbGeAlD
Irbesartan—Anorexia—Acamprosate—alcohol dependence	0.000492	0.00162	CcSEcCtD
Irbesartan—Hyperglycaemia—Citalopram—alcohol dependence	0.000491	0.00161	CcSEcCtD
Irbesartan—CYP2D6—digestive system—alcohol dependence	0.000491	0.00587	CbGeAlD
Irbesartan—Oedema—Naltrexone—alcohol dependence	0.000489	0.00161	CcSEcCtD
Irbesartan—Anaphylactic shock—Naltrexone—alcohol dependence	0.000489	0.00161	CcSEcCtD
Irbesartan—Pneumonia—Citalopram—alcohol dependence	0.000488	0.00161	CcSEcCtD
Irbesartan—CYP2C9—liver—alcohol dependence	0.000488	0.00583	CbGeAlD
Irbesartan—Infection—Naltrexone—alcohol dependence	0.000486	0.0016	CcSEcCtD
Irbesartan—Hypotension—Acamprosate—alcohol dependence	0.000483	0.00159	CcSEcCtD
Irbesartan—Shock—Naltrexone—alcohol dependence	0.000481	0.00158	CcSEcCtD
Irbesartan—Nervous system disorder—Naltrexone—alcohol dependence	0.000479	0.00158	CcSEcCtD
Irbesartan—Acute coronary syndrome—Citalopram—alcohol dependence	0.000479	0.00157	CcSEcCtD
Irbesartan—Tachycardia—Naltrexone—alcohol dependence	0.000477	0.00157	CcSEcCtD
Irbesartan—Myocardial infarction—Citalopram—alcohol dependence	0.000476	0.00156	CcSEcCtD
Irbesartan—CYP3A4—blood—alcohol dependence	0.000476	0.00568	CbGeAlD
Irbesartan—Skin disorder—Naltrexone—alcohol dependence	0.000475	0.00156	CcSEcCtD
Irbesartan—Jaundice—Citalopram—alcohol dependence	0.000473	0.00156	CcSEcCtD
Irbesartan—Hyperhidrosis—Naltrexone—alcohol dependence	0.000473	0.00155	CcSEcCtD
Irbesartan—Conjunctivitis—Citalopram—alcohol dependence	0.000472	0.00155	CcSEcCtD
Irbesartan—Urinary tract infection—Citalopram—alcohol dependence	0.000472	0.00155	CcSEcCtD
Irbesartan—PTGS1—testis—alcohol dependence	0.000471	0.00563	CbGeAlD
Irbesartan—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000471	0.00155	CcSEcCtD
Irbesartan—CYP2D6—blood—alcohol dependence	0.000468	0.00559	CbGeAlD
Irbesartan—Anorexia—Naltrexone—alcohol dependence	0.000466	0.00153	CcSEcCtD
Irbesartan—Paraesthesia—Acamprosate—alcohol dependence	0.000464	0.00152	CcSEcCtD
Irbesartan—PTGS1—nervous system—alcohol dependence	0.000462	0.00553	CbGeAlD
Irbesartan—Dyspnoea—Acamprosate—alcohol dependence	0.000461	0.00151	CcSEcCtD
Irbesartan—Somnolence—Acamprosate—alcohol dependence	0.000459	0.00151	CcSEcCtD
Irbesartan—Hepatobiliary disease—Citalopram—alcohol dependence	0.000459	0.00151	CcSEcCtD
Irbesartan—Epistaxis—Citalopram—alcohol dependence	0.000458	0.00151	CcSEcCtD
Irbesartan—Dyspepsia—Acamprosate—alcohol dependence	0.000455	0.00149	CcSEcCtD
Irbesartan—Agranulocytosis—Citalopram—alcohol dependence	0.000453	0.00149	CcSEcCtD
Irbesartan—Decreased appetite—Acamprosate—alcohol dependence	0.000449	0.00148	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000446	0.00147	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000445	0.00146	CcSEcCtD
Irbesartan—PTGS1—central nervous system—alcohol dependence	0.000445	0.00532	CbGeAlD
Irbesartan—Bradycardia—Citalopram—alcohol dependence	0.000444	0.00146	CcSEcCtD
Irbesartan—Pain—Acamprosate—alcohol dependence	0.000442	0.00145	CcSEcCtD
Irbesartan—Constipation—Acamprosate—alcohol dependence	0.000442	0.00145	CcSEcCtD
Irbesartan—Paraesthesia—Naltrexone—alcohol dependence	0.000439	0.00144	CcSEcCtD
Irbesartan—Rhinitis—Citalopram—alcohol dependence	0.000437	0.00144	CcSEcCtD
Irbesartan—Hepatitis—Citalopram—alcohol dependence	0.000436	0.00143	CcSEcCtD
Irbesartan—Dyspnoea—Naltrexone—alcohol dependence	0.000436	0.00143	CcSEcCtD
Irbesartan—CYP2C8—brain—alcohol dependence	0.000436	0.00521	CbGeAlD
Irbesartan—Somnolence—Naltrexone—alcohol dependence	0.000435	0.00143	CcSEcCtD
Irbesartan—Hypoaesthesia—Citalopram—alcohol dependence	0.000434	0.00143	CcSEcCtD
Irbesartan—Pharyngitis—Citalopram—alcohol dependence	0.000433	0.00142	CcSEcCtD
Irbesartan—Urinary tract disorder—Citalopram—alcohol dependence	0.000431	0.00142	CcSEcCtD
Irbesartan—Oedema peripheral—Citalopram—alcohol dependence	0.000429	0.00141	CcSEcCtD
Irbesartan—Connective tissue disorder—Citalopram—alcohol dependence	0.000428	0.00141	CcSEcCtD
Irbesartan—Urethral disorder—Citalopram—alcohol dependence	0.000427	0.0014	CcSEcCtD
Irbesartan—Feeling abnormal—Acamprosate—alcohol dependence	0.000426	0.0014	CcSEcCtD
Irbesartan—Decreased appetite—Naltrexone—alcohol dependence	0.000425	0.0014	CcSEcCtD
Irbesartan—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000422	0.00139	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000422	0.00139	CcSEcCtD
Irbesartan—Fatigue—Naltrexone—alcohol dependence	0.000421	0.00139	CcSEcCtD
Irbesartan—Visual impairment—Citalopram—alcohol dependence	0.00042	0.00138	CcSEcCtD
Irbesartan—Pain—Naltrexone—alcohol dependence	0.000418	0.00137	CcSEcCtD
Irbesartan—Constipation—Naltrexone—alcohol dependence	0.000418	0.00137	CcSEcCtD
Irbesartan—CYP3A4—endocrine gland—alcohol dependence	0.000413	0.00493	CbGeAlD
Irbesartan—Urticaria—Acamprosate—alcohol dependence	0.00041	0.00135	CcSEcCtD
Irbesartan—Body temperature increased—Acamprosate—alcohol dependence	0.000408	0.00134	CcSEcCtD
Irbesartan—Abdominal pain—Acamprosate—alcohol dependence	0.000408	0.00134	CcSEcCtD
Irbesartan—Tinnitus—Citalopram—alcohol dependence	0.000406	0.00134	CcSEcCtD
Irbesartan—CYP2D6—endocrine gland—alcohol dependence	0.000406	0.00485	CbGeAlD
Irbesartan—Cardiac disorder—Citalopram—alcohol dependence	0.000405	0.00133	CcSEcCtD
Irbesartan—Flushing—Citalopram—alcohol dependence	0.000405	0.00133	CcSEcCtD
Irbesartan—Feeling abnormal—Naltrexone—alcohol dependence	0.000403	0.00132	CcSEcCtD
Irbesartan—Gastrointestinal pain—Naltrexone—alcohol dependence	0.0004	0.00131	CcSEcCtD
Irbesartan—Angiopathy—Citalopram—alcohol dependence	0.000396	0.0013	CcSEcCtD
Irbesartan—Immune system disorder—Citalopram—alcohol dependence	0.000394	0.00129	CcSEcCtD
Irbesartan—Mediastinal disorder—Citalopram—alcohol dependence	0.000393	0.00129	CcSEcCtD
Irbesartan—Chills—Citalopram—alcohol dependence	0.000391	0.00129	CcSEcCtD
Irbesartan—Arrhythmia—Citalopram—alcohol dependence	0.000389	0.00128	CcSEcCtD
Irbesartan—Urticaria—Naltrexone—alcohol dependence	0.000388	0.00128	CcSEcCtD
Irbesartan—CYP2D6—testis—alcohol dependence	0.000387	0.00463	CbGeAlD
Irbesartan—Abdominal pain—Naltrexone—alcohol dependence	0.000386	0.00127	CcSEcCtD
Irbesartan—Body temperature increased—Naltrexone—alcohol dependence	0.000386	0.00127	CcSEcCtD
Irbesartan—CYP3A4—nervous system—alcohol dependence	0.000386	0.00461	CbGeAlD
Irbesartan—Hypersensitivity—Acamprosate—alcohol dependence	0.000381	0.00125	CcSEcCtD
Irbesartan—CYP2D6—nervous system—alcohol dependence	0.00038	0.00454	CbGeAlD
Irbesartan—Erythema—Citalopram—alcohol dependence	0.00038	0.00125	CcSEcCtD
Irbesartan—Malnutrition—Citalopram—alcohol dependence	0.00038	0.00125	CcSEcCtD
Irbesartan—Flatulence—Citalopram—alcohol dependence	0.000374	0.00123	CcSEcCtD
Irbesartan—Tension—Citalopram—alcohol dependence	0.000372	0.00122	CcSEcCtD
Irbesartan—CYP3A4—liver—alcohol dependence	0.000372	0.00445	CbGeAlD
Irbesartan—CYP3A4—central nervous system—alcohol dependence	0.000372	0.00444	CbGeAlD
Irbesartan—Dysgeusia—Citalopram—alcohol dependence	0.000372	0.00122	CcSEcCtD
Irbesartan—Asthenia—Acamprosate—alcohol dependence	0.000371	0.00122	CcSEcCtD
Irbesartan—Nervousness—Citalopram—alcohol dependence	0.000369	0.00121	CcSEcCtD
Irbesartan—CYP2D6—liver—alcohol dependence	0.000366	0.00437	CbGeAlD
Irbesartan—CYP2D6—central nervous system—alcohol dependence	0.000366	0.00437	CbGeAlD
Irbesartan—Pruritus—Acamprosate—alcohol dependence	0.000366	0.0012	CcSEcCtD
Irbesartan—Muscle spasms—Citalopram—alcohol dependence	0.000365	0.0012	CcSEcCtD
Irbesartan—Hypersensitivity—Naltrexone—alcohol dependence	0.00036	0.00118	CcSEcCtD
Irbesartan—Vision blurred—Citalopram—alcohol dependence	0.000358	0.00118	CcSEcCtD
Irbesartan—CYP2D6—cerebellum—alcohol dependence	0.000358	0.00427	CbGeAlD
Irbesartan—Tremor—Citalopram—alcohol dependence	0.000356	0.00117	CcSEcCtD
Irbesartan—Diarrhoea—Acamprosate—alcohol dependence	0.000354	0.00116	CcSEcCtD
Irbesartan—PTGS1—brain—alcohol dependence	0.000353	0.00422	CbGeAlD
Irbesartan—Ill-defined disorder—Citalopram—alcohol dependence	0.000352	0.00116	CcSEcCtD
Irbesartan—Anaemia—Citalopram—alcohol dependence	0.000351	0.00115	CcSEcCtD
Irbesartan—Asthenia—Naltrexone—alcohol dependence	0.000351	0.00115	CcSEcCtD
Irbesartan—Agitation—Citalopram—alcohol dependence	0.000349	0.00115	CcSEcCtD
Irbesartan—Angioedema—Citalopram—alcohol dependence	0.000347	0.00114	CcSEcCtD
Irbesartan—Pruritus—Naltrexone—alcohol dependence	0.000346	0.00114	CcSEcCtD
Irbesartan—Malaise—Citalopram—alcohol dependence	0.000342	0.00112	CcSEcCtD
Irbesartan—Dizziness—Acamprosate—alcohol dependence	0.000342	0.00112	CcSEcCtD
Irbesartan—Vertigo—Citalopram—alcohol dependence	0.000341	0.00112	CcSEcCtD
Irbesartan—Syncope—Citalopram—alcohol dependence	0.00034	0.00112	CcSEcCtD
Irbesartan—Leukopenia—Citalopram—alcohol dependence	0.00034	0.00112	CcSEcCtD
Irbesartan—Diarrhoea—Naltrexone—alcohol dependence	0.000334	0.0011	CcSEcCtD
Irbesartan—Loss of consciousness—Citalopram—alcohol dependence	0.000334	0.0011	CcSEcCtD
Irbesartan—Cough—Citalopram—alcohol dependence	0.000331	0.00109	CcSEcCtD
Irbesartan—Vomiting—Acamprosate—alcohol dependence	0.000328	0.00108	CcSEcCtD
Irbesartan—Hypertension—Citalopram—alcohol dependence	0.000328	0.00108	CcSEcCtD
Irbesartan—Rash—Acamprosate—alcohol dependence	0.000326	0.00107	CcSEcCtD
Irbesartan—Dermatitis—Acamprosate—alcohol dependence	0.000325	0.00107	CcSEcCtD
Irbesartan—Headache—Acamprosate—alcohol dependence	0.000324	0.00106	CcSEcCtD
Irbesartan—Dizziness—Naltrexone—alcohol dependence	0.000323	0.00106	CcSEcCtD
Irbesartan—Arthralgia—Citalopram—alcohol dependence	0.000323	0.00106	CcSEcCtD
Irbesartan—Chest pain—Citalopram—alcohol dependence	0.000323	0.00106	CcSEcCtD
Irbesartan—Myalgia—Citalopram—alcohol dependence	0.000323	0.00106	CcSEcCtD
Irbesartan—Anxiety—Citalopram—alcohol dependence	0.000322	0.00106	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000321	0.00105	CcSEcCtD
Irbesartan—Discomfort—Citalopram—alcohol dependence	0.000319	0.00105	CcSEcCtD
Irbesartan—Dry mouth—Citalopram—alcohol dependence	0.000316	0.00104	CcSEcCtD
Irbesartan—Vomiting—Naltrexone—alcohol dependence	0.000311	0.00102	CcSEcCtD
Irbesartan—Anaphylactic shock—Citalopram—alcohol dependence	0.00031	0.00102	CcSEcCtD
Irbesartan—Oedema—Citalopram—alcohol dependence	0.00031	0.00102	CcSEcCtD
Irbesartan—Rash—Naltrexone—alcohol dependence	0.000308	0.00101	CcSEcCtD
Irbesartan—Dermatitis—Naltrexone—alcohol dependence	0.000308	0.00101	CcSEcCtD
Irbesartan—Infection—Citalopram—alcohol dependence	0.000308	0.00101	CcSEcCtD
Irbesartan—Nausea—Acamprosate—alcohol dependence	0.000307	0.00101	CcSEcCtD
Irbesartan—Headache—Naltrexone—alcohol dependence	0.000306	0.00101	CcSEcCtD
Irbesartan—Shock—Citalopram—alcohol dependence	0.000305	0.001	CcSEcCtD
Irbesartan—Nervous system disorder—Citalopram—alcohol dependence	0.000304	0.000998	CcSEcCtD
Irbesartan—Thrombocytopenia—Citalopram—alcohol dependence	0.000303	0.000997	CcSEcCtD
Irbesartan—Tachycardia—Citalopram—alcohol dependence	0.000302	0.000994	CcSEcCtD
Irbesartan—Skin disorder—Citalopram—alcohol dependence	0.000301	0.000989	CcSEcCtD
Irbesartan—Hyperhidrosis—Citalopram—alcohol dependence	0.000299	0.000984	CcSEcCtD
Irbesartan—Anorexia—Citalopram—alcohol dependence	0.000295	0.00097	CcSEcCtD
Irbesartan—CYP2D6—brain—alcohol dependence	0.00029	0.00347	CbGeAlD
Irbesartan—Nausea—Naltrexone—alcohol dependence	0.00029	0.000954	CcSEcCtD
Irbesartan—Hypotension—Citalopram—alcohol dependence	0.000289	0.000951	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000282	0.000927	CcSEcCtD
Irbesartan—Paraesthesia—Citalopram—alcohol dependence	0.000278	0.000914	CcSEcCtD
Irbesartan—Dyspnoea—Citalopram—alcohol dependence	0.000276	0.000908	CcSEcCtD
Irbesartan—Somnolence—Citalopram—alcohol dependence	0.000275	0.000905	CcSEcCtD
Irbesartan—Dyspepsia—Citalopram—alcohol dependence	0.000273	0.000896	CcSEcCtD
Irbesartan—Decreased appetite—Citalopram—alcohol dependence	0.000269	0.000885	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000267	0.000879	CcSEcCtD
Irbesartan—Fatigue—Citalopram—alcohol dependence	0.000267	0.000878	CcSEcCtD
Irbesartan—Pain—Citalopram—alcohol dependence	0.000265	0.000871	CcSEcCtD
Irbesartan—Constipation—Citalopram—alcohol dependence	0.000265	0.000871	CcSEcCtD
Irbesartan—Feeling abnormal—Citalopram—alcohol dependence	0.000255	0.000839	CcSEcCtD
Irbesartan—Gastrointestinal pain—Citalopram—alcohol dependence	0.000253	0.000832	CcSEcCtD
Irbesartan—Urticaria—Citalopram—alcohol dependence	0.000246	0.000809	CcSEcCtD
Irbesartan—Body temperature increased—Citalopram—alcohol dependence	0.000245	0.000805	CcSEcCtD
Irbesartan—Abdominal pain—Citalopram—alcohol dependence	0.000245	0.000805	CcSEcCtD
Irbesartan—Hypersensitivity—Citalopram—alcohol dependence	0.000228	0.00075	CcSEcCtD
Irbesartan—Asthenia—Citalopram—alcohol dependence	0.000222	0.00073	CcSEcCtD
Irbesartan—Pruritus—Citalopram—alcohol dependence	0.000219	0.00072	CcSEcCtD
Irbesartan—Diarrhoea—Citalopram—alcohol dependence	0.000212	0.000697	CcSEcCtD
Irbesartan—Dizziness—Citalopram—alcohol dependence	0.000205	0.000673	CcSEcCtD
Irbesartan—Vomiting—Citalopram—alcohol dependence	0.000197	0.000647	CcSEcCtD
Irbesartan—Rash—Citalopram—alcohol dependence	0.000195	0.000642	CcSEcCtD
Irbesartan—Dermatitis—Citalopram—alcohol dependence	0.000195	0.000641	CcSEcCtD
Irbesartan—Headache—Citalopram—alcohol dependence	0.000194	0.000638	CcSEcCtD
Irbesartan—Nausea—Citalopram—alcohol dependence	0.000184	0.000605	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—NPY—alcohol dependence	0.000125	0.000631	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—POMC—alcohol dependence	0.000124	0.000625	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000124	0.000624	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—OPRM1—alcohol dependence	0.000124	0.000623	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ADH7—alcohol dependence	0.000124	0.000623	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—DRD4—alcohol dependence	0.000122	0.000616	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR2A—alcohol dependence	0.000122	0.000615	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—OPRD1—alcohol dependence	0.000121	0.000609	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR1B—alcohol dependence	0.000121	0.000609	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CRH—alcohol dependence	0.000121	0.000609	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—EP300—alcohol dependence	0.000121	0.000608	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—GGT1—alcohol dependence	0.000119	0.000601	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GGT2—alcohol dependence	0.000118	0.000597	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CNR1—alcohol dependence	0.000117	0.000588	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADH6—alcohol dependence	0.000116	0.000586	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PDYN—alcohol dependence	0.000116	0.000584	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR7—alcohol dependence	0.000114	0.000574	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—DRD2—alcohol dependence	0.000114	0.000574	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—NPY—alcohol dependence	0.000114	0.000573	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000113	0.000572	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000113	0.000569	CbGpPWpGaD
Irbesartan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000112	0.000566	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000111	0.000558	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR1B—alcohol dependence	0.00011	0.000553	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CRH—alcohol dependence	0.00011	0.000553	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ADH1B—alcohol dependence	0.000108	0.000546	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000108	0.000544	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CRHR1—alcohol dependence	0.000108	0.000543	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—WASF2—alcohol dependence	0.000108	0.000543	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—POMC—alcohol dependence	0.000108	0.000543	CbGpPWpGaD
Irbesartan—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000107	0.000542	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—MAOA—alcohol dependence	0.000107	0.000538	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000107	0.000537	CbGpPWpGaD
Irbesartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000106	0.000537	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000106	0.000533	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—DRD4—alcohol dependence	0.000106	0.000532	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AVP—alcohol dependence	0.000105	0.000532	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—OPRK1—alcohol dependence	0.000105	0.000532	CbGpPWpGaD
Irbesartan—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000105	0.00053	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000104	0.000525	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—WASF1—alcohol dependence	0.000103	0.000521	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000102	0.000517	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CHRM2—alcohol dependence	0.000101	0.000511	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CNR1—alcohol dependence	0.000101	0.000508	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR7—alcohol dependence	9.83e-05	0.000496	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—DRD2—alcohol dependence	9.83e-05	0.000496	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—GGT1—alcohol dependence	9.78e-05	0.000493	CbGpPWpGaD
Irbesartan—JUN—Immune System—WASF2—alcohol dependence	9.77e-05	0.000493	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—POMC—alcohol dependence	9.73e-05	0.000491	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—GGT1—alcohol dependence	9.7e-05	0.000489	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADH1A—alcohol dependence	9.62e-05	0.000485	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—DRD4—alcohol dependence	9.59e-05	0.000483	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AVP—alcohol dependence	9.58e-05	0.000483	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—OPRD1—alcohol dependence	9.48e-05	0.000478	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	9.4e-05	0.000474	CbGpPWpGaD
Irbesartan—JUN—Immune System—WASF1—alcohol dependence	9.36e-05	0.000472	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—OPRM1—alcohol dependence	9.3e-05	0.000469	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	9.21e-05	0.000464	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	9.21e-05	0.000464	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CNR1—alcohol dependence	9.15e-05	0.000462	CbGpPWpGaD
Irbesartan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	9.1e-05	0.000459	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PDYN—alcohol dependence	9.09e-05	0.000458	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—EP300—alcohol dependence	9.03e-05	0.000455	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	9.02e-05	0.000455	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MAOB—alcohol dependence	8.97e-05	0.000453	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR7—alcohol dependence	8.93e-05	0.00045	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—DRD2—alcohol dependence	8.93e-05	0.00045	CbGpPWpGaD
Irbesartan—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	8.9e-05	0.000449	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR2A—alcohol dependence	8.78e-05	0.000443	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—MAOA—alcohol dependence	8.77e-05	0.000442	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	8.71e-05	0.000439	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—MAOA—alcohol dependence	8.69e-05	0.000438	CbGpPWpGaD
Irbesartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	8.66e-05	0.000437	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NPY—alcohol dependence	8.56e-05	0.000432	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CRHR1—alcohol dependence	8.45e-05	0.000426	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—WASF2—alcohol dependence	8.45e-05	0.000426	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GGT1—alcohol dependence	8.29e-05	0.000418	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AVP—alcohol dependence	8.28e-05	0.000417	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CRH—alcohol dependence	8.26e-05	0.000416	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR1B—alcohol dependence	8.26e-05	0.000416	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADH4—alcohol dependence	8.18e-05	0.000413	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—WASF1—alcohol dependence	8.1e-05	0.000409	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR2A—alcohol dependence	7.97e-05	0.000402	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CHRM2—alcohol dependence	7.95e-05	0.000401	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALDH2—alcohol dependence	7.63e-05	0.000385	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AVP—alcohol dependence	7.52e-05	0.000379	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADH6—alcohol dependence	7.5e-05	0.000378	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—MAOA—alcohol dependence	7.43e-05	0.000374	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—OPRM1—alcohol dependence	7.3e-05	0.000368	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—EP300—alcohol dependence	7.26e-05	0.000366	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—DRD4—alcohol dependence	7.22e-05	0.000364	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—OPRD1—alcohol dependence	7.08e-05	0.000357	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.08e-05	0.000357	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.02e-05	0.000354	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—POMC—alcohol dependence	7.01e-05	0.000353	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	6.97e-05	0.000351	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADH7—alcohol dependence	6.96e-05	0.000351	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—POMC—alcohol dependence	6.95e-05	0.000351	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CNR1—alcohol dependence	6.89e-05	0.000347	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR2A—alcohol dependence	6.89e-05	0.000347	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	6.87e-05	0.000346	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PDYN—alcohol dependence	6.79e-05	0.000343	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR7—alcohol dependence	6.72e-05	0.000339	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—DRD2—alcohol dependence	6.72e-05	0.000339	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NPY—alcohol dependence	6.71e-05	0.000339	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GGT2—alcohol dependence	6.67e-05	0.000336	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT2—alcohol dependence	6.49e-05	0.000327	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CRH—alcohol dependence	6.48e-05	0.000327	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR1B—alcohol dependence	6.48e-05	0.000327	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GGT1—alcohol dependence	6.39e-05	0.000322	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—POMC—alcohol dependence	6.37e-05	0.000321	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CRHR1—alcohol dependence	6.31e-05	0.000318	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—WASF2—alcohol dependence	6.31e-05	0.000318	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR2A—alcohol dependence	6.25e-05	0.000315	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADH1A—alcohol dependence	6.21e-05	0.000313	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADH6—alcohol dependence	6.16e-05	0.000311	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADH6—alcohol dependence	6.1e-05	0.000308	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADH1B—alcohol dependence	6.1e-05	0.000308	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYP2E1—alcohol dependence	6.1e-05	0.000308	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—WASF1—alcohol dependence	6.05e-05	0.000305	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CHRM2—alcohol dependence	5.94e-05	0.000299	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—MAOA—alcohol dependence	5.73e-05	0.000289	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—POMC—alcohol dependence	5.71e-05	0.000288	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—DRD4—alcohol dependence	5.66e-05	0.000286	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AVP—alcohol dependence	5.66e-05	0.000285	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—POMC—alcohol dependence	5.66e-05	0.000285	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT1—alcohol dependence	5.6e-05	0.000282	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GGT1—alcohol dependence	5.6e-05	0.000282	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—POMC—alcohol dependence	5.5e-05	0.000277	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—OPRM1—alcohol dependence	5.45e-05	0.000275	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CNR1—alcohol dependence	5.41e-05	0.000273	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADH4—alcohol dependence	5.28e-05	0.000266	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR7—alcohol dependence	5.27e-05	0.000266	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—DRD2—alcohol dependence	5.27e-05	0.000266	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADH6—alcohol dependence	5.22e-05	0.000263	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADH1A—alcohol dependence	5.1e-05	0.000257	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADH1A—alcohol dependence	5.06e-05	0.000255	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MAOB—alcohol dependence	5.05e-05	0.000255	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MAOA—alcohol dependence	5.02e-05	0.000253	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NPY—alcohol dependence	5.02e-05	0.000253	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—POMC—alcohol dependence	4.99e-05	0.000252	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR1B—alcohol dependence	4.84e-05	0.000244	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CRH—alcohol dependence	4.84e-05	0.000244	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—POMC—alcohol dependence	4.83e-05	0.000244	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR2A—alcohol dependence	4.71e-05	0.000237	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.57e-05	0.000231	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADH7—alcohol dependence	4.49e-05	0.000227	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AVP—alcohol dependence	4.44e-05	0.000224	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADH4—alcohol dependence	4.34e-05	0.000219	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADH1A—alcohol dependence	4.32e-05	0.000218	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT2—alcohol dependence	4.31e-05	0.000217	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADH4—alcohol dependence	4.3e-05	0.000217	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALDH2—alcohol dependence	4.3e-05	0.000217	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD4—alcohol dependence	4.23e-05	0.000213	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.13e-05	0.000208	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CNR1—alcohol dependence	4.04e-05	0.000204	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADH6—alcohol dependence	4.03e-05	0.000203	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR7—alcohol dependence	3.94e-05	0.000199	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD2—alcohol dependence	3.94e-05	0.000199	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADH1B—alcohol dependence	3.94e-05	0.000199	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EP300—alcohol dependence	3.88e-05	0.000196	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—POMC—alcohol dependence	3.76e-05	0.00019	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—POMC—alcohol dependence	3.73e-05	0.000188	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.72e-05	0.000188	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2A—alcohol dependence	3.69e-05	0.000186	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADH7—alcohol dependence	3.69e-05	0.000186	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADH4—alcohol dependence	3.68e-05	0.000185	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADH7—alcohol dependence	3.66e-05	0.000184	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT2—alcohol dependence	3.65e-05	0.000184	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT2—alcohol dependence	3.54e-05	0.000178	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT2—alcohol dependence	3.51e-05	0.000177	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP2E1—alcohol dependence	3.44e-05	0.000173	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.34e-05	0.000168	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AVP—alcohol dependence	3.32e-05	0.000167	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—alcohol dependence	3.27e-05	0.000165	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOB—alcohol dependence	3.26e-05	0.000165	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADH1B—alcohol dependence	3.23e-05	0.000163	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADH1B—alcohol dependence	3.21e-05	0.000162	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.18e-05	0.00016	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT1—alcohol dependence	3.15e-05	0.000159	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GGT1—alcohol dependence	3.15e-05	0.000159	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADH7—alcohol dependence	3.12e-05	0.000158	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT2—alcohol dependence	3e-05	0.000151	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—alcohol dependence	2.95e-05	0.000149	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADH4—alcohol dependence	2.84e-05	0.000143	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MAOA—alcohol dependence	2.83e-05	0.000143	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALDH2—alcohol dependence	2.78e-05	0.00014	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2A—alcohol dependence	2.76e-05	0.000139	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.74e-05	0.000138	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADH1B—alcohol dependence	2.74e-05	0.000138	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOB—alcohol dependence	2.68e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.67e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOB—alcohol dependence	2.66e-05	0.000134	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EP300—alcohol dependence	2.49e-05	0.000126	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADH7—alcohol dependence	2.41e-05	0.000122	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT2—alcohol dependence	2.36e-05	0.000119	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT2—alcohol dependence	2.31e-05	0.000117	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALDH2—alcohol dependence	2.28e-05	0.000115	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOB—alcohol dependence	2.27e-05	0.000114	CbGpPWpGaD
Irbesartan—JUN—Immune System—EP300—alcohol dependence	2.26e-05	0.000114	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALDH2—alcohol dependence	2.26e-05	0.000114	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2E1—alcohol dependence	2.22e-05	0.000112	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—alcohol dependence	2.2e-05	0.000111	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.17e-05	0.00011	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—EP300—alcohol dependence	2.17e-05	0.000109	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.11e-05	0.000107	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT1—alcohol dependence	2.04e-05	0.000103	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT1—alcohol dependence	2.04e-05	0.000103	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EP300—alcohol dependence	1.96e-05	9.87e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT2—alcohol dependence	1.94e-05	9.77e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALDH2—alcohol dependence	1.93e-05	9.74e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT2—alcohol dependence	1.92e-05	9.69e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.86e-05	9.36e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—alcohol dependence	1.84e-05	9.28e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOA—alcohol dependence	1.83e-05	9.21e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP2E1—alcohol dependence	1.82e-05	9.19e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2E1—alcohol dependence	1.81e-05	9.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.77e-05	8.93e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOB—alcohol dependence	1.75e-05	8.84e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—alcohol dependence	1.67e-05	8.43e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT1—alcohol dependence	1.67e-05	8.43e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT1—alcohol dependence	1.66e-05	8.36e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—alcohol dependence	1.66e-05	8.36e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT2—alcohol dependence	1.64e-05	8.28e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2E1—alcohol dependence	1.54e-05	7.78e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOA—alcohol dependence	1.5e-05	7.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.49e-05	7.51e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOA—alcohol dependence	1.49e-05	7.49e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EP300—alcohol dependence	1.46e-05	7.37e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.44e-05	7.27e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—alcohol dependence	1.42e-05	7.15e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT1—alcohol dependence	1.42e-05	7.15e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOA—alcohol dependence	1.27e-05	6.4e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT2—alcohol dependence	1.27e-05	6.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.23e-05	6.21e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—EP300—alcohol dependence	1.22e-05	6.16e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.19e-05	6.01e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—alcohol dependence	1.19e-05	5.99e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—alcohol dependence	1.09e-05	5.51e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT1—alcohol dependence	1.09e-05	5.51e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOA—alcohol dependence	9.8e-06	4.94e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—alcohol dependence	9.76e-06	4.92e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—alcohol dependence	9.67e-06	4.88e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—alcohol dependence	8.27e-06	4.17e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—EP300—alcohol dependence	7.89e-06	3.98e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—EP300—alcohol dependence	6.47e-06	3.26e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—EP300—alcohol dependence	6.42e-06	3.24e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—alcohol dependence	6.38e-06	3.22e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—EP300—alcohol dependence	5.48e-06	2.77e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—EP300—alcohol dependence	4.23e-06	2.13e-05	CbGpPWpGaD
